Champions Oncology (CSBR) Tops Q2 EPS by 1c

Champions Oncology (NASDAQ: CSBR) reported Q2 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $11.57 million versus the consensus estimate of $12.82 million.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Royal Unibrew reports higher interim first-half profit as margins improve
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c